Ruoxi He
Papers
1
Total Citations
24
H-Index
1
About
Dr. Ruoxi He is a pioneering thoracic surgeon whose research focuses on the intersection of advanced surgical robotics and multimodal cancer therapy for non-small cell lung cancer (NSCLC). Her most cited work, a 2022 real-world prospective cohort study, investigates the feasibility and safety of robotic-assisted thoracic surgery following neoadjuvant chemoimmunotherapy in patients with stage III NSCLC—a notoriously heterogeneous and challenging disease subset with poor prognosis. This landmark study, with 24 citations, provides critical evidence that robotic surgery can be safely integrated after modern induction regimens, potentially expanding surgical options for patients previously considered borderline resectable. Dr. He’s major contribution lies in demonstrating that minimally invasive robotic techniques can be effectively combined with immunotherapy-based neoadjuvant protocols, addressing a key clinical debate in stage III NSCLC management. Her work bridges the gap between cutting-edge immunotherapy and precision surgery, offering new hope for improved outcomes in this difficult patient population. By systematically evaluating perioperative safety and feasibility, Dr. He is helping to redefine surgical standards for advanced lung cancer, making her a rising authority in thoracic oncology and robotic surgery.
Research Focus
Key Achievements
Top Papers
- 1